The goal of the Invention to Startup forum is to support
Dr. Timothy Corson will talk about the “Novel compounds and targets for blocking neovascularization”.
Dr. Corson is an associate professor in the Department of Ophthalmology, Showalter Scholar and Director of Basic and Translational Research in the Eugene and Marilyn Glick Eye Institute. He is also a member of the IU Melvin and Bren Simon Cancer Center, Stark Neurosciences Research Institute, and Center for Diabetes and Metabolic Diseases